- Home
- VEL vs FTRE Comparison
VEL vs FTRE Comparison
Compare VEL & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEL
- FTRE
- Stock Information
- Founded
- VEL 2004
- FTRE 1996
- Country
- VEL United States
- FTRE United States
- Employees
- VEL N/A
- FTRE N/A
- Industry
- VEL Finance: Consumer Services
- FTRE Medical Specialities
- Sector
- VEL Finance
- FTRE Health Care
- Exchange
- VEL Nasdaq
- FTRE Nasdaq
- Market Cap
- VEL 726.9M
- FTRE 864.4M
- IPO Year
- VEL 2020
- FTRE N/A
- Fundamental
- Price
- VEL $18.37
- FTRE $10.16
- Analyst Decision
- VEL Strong Buy
- FTRE Hold
- Analyst Count
- VEL 4
- FTRE 8
- Target Price
- VEL $21.75
- FTRE $11.64
- AVG Volume (30 Days)
- VEL 55.9K
- FTRE 1.3M
- Earning Date
- VEL 11-06-2025
- FTRE 11-05-2025
- Dividend Yield
- VEL N/A
- FTRE N/A
- EPS Growth
- VEL 32.26
- FTRE N/A
- EPS
- VEL 2.43
- FTRE N/A
- Revenue
- VEL $229,360,000.00
- FTRE $2,759,900,000.00
- Revenue This Year
- VEL $3.99
- FTRE $0.47
- Revenue Next Year
- VEL $29.69
- FTRE N/A
- P/E Ratio
- VEL $7.55
- FTRE N/A
- Revenue Growth
- VEL 116.81
- FTRE 1.88
- 52 Week Low
- VEL $16.12
- FTRE $3.97
- 52 Week High
- VEL $20.98
- FTRE $25.05
- Technical
- Relative Strength Index (RSI)
- VEL 49.91
- FTRE 49.55
- Support Level
- VEL $18.04
- FTRE $9.60
- Resistance Level
- VEL $18.67
- FTRE $10.70
- Average True Range (ATR)
- VEL 0.33
- FTRE 0.97
- MACD
- VEL -0.04
- FTRE -0.14
- Stochastic Oscillator
- VEL 28.57
- FTRE 24.62
About VEL Velocity Financial Inc.
Velocity Financial Inc is a United States-based real estate finance company. The company originates and manages investor loans secured by residential rental and small commercial properties. The company earns revenue in the form of interest income. It operates in New York, California, Florida, New Jersey, and other states.
About FTRE Fortrea Holdings Inc.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.